A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants

An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis

NCT02497469 ·Status: COMPLETED ·Phase: PHASE3

A Study of Kynteles Injection (Vedolizumab) in Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease or Chronic Pouchitis

NCT04799496 ·Status: COMPLETED

Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative Colitis

NCT02611830 ·Status: COMPLETED ·Phase: PHASE3

Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

NCT03824561 ·Status: COMPLETED

A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants

NCT03710486 ·Status: COMPLETED

A Study to Assess the Effectiveness and Safety of Treatment With Vedolizumab in Adult Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real Life

NCT03378388 ·Status: TERMINATED

A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

NCT02620046 ·Status: COMPLETED ·Phase: PHASE3

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

NCT03679546 ·Status: COMPLETED ·Phase: PHASE4

Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

NCT02913508 ·Status: WITHDRAWN ·Phase: PHASE2

Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative Colitis

NCT03029143 ·Status: COMPLETED ·Phase: PHASE4

Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis

NCT03839680 ·Status: UNKNOWN

Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis

NCT05481619 ·Status: RECRUITING ·Phase: PHASE4

An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of Vedolizumab

NCT06855862 ·Status: COMPLETED

A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

NCT05384080 ·Status: COMPLETED

the Long-term Retention Rate and Influence Factors of Individualized Treatment of Vedolizumab in Ulcerative Colitis

NCT06856031 ·Status: COMPLETED

Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients

NCT04071405 ·Status: COMPLETED

An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis

NCT02646657 ·Status: COMPLETED ·Phase: PHASE4

Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC

NCT02954159 ·Status: TERMINATED ·Phase: PHASE3

Value of Pharmacokinetic Assays in the Prediction of Therapeutic Response in Ulcerative Colitis

NCT03724929 ·Status: TERMINATED ·Phase: NA

Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

NCT06850727 ·Status: RECRUITING ·Phase: PHASE2

Prediction Model for Response to Biologics and Small Molecular Agent for UC

NCT05186623 ·Status: RECRUITING

VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease

NCT03257345 ·Status: UNKNOWN

Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.

NCT03234907 ·Status: COMPLETED ·Phase: PHASE3

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in Real-World Practice

NCT04890262 ·Status: COMPLETED

A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting

NCT06581328 ·Status: RECRUITING ·Phase: PHASE4